Prevention of Seasonal Affective Disorder

This study has been completed.

First Received on September 30, 2002. Last Updated on July 26, 2010 History of Changes

Sponsor:	GlaxoSmithKline
Information provided by:	GlaxoSmithKline
ClinicalTrials.gov Identifier:	NCT00046449

Purpose

A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

Condition	Intervention	Phase
Seasonal Affective Disorder (SAD)	Drug: Investigational Seasonal Affective Disorder (SAD) Drug	Phase III

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment

Resource links provided by NLM:

MedlinePlus related topics: Seasonal Affective Disorder

U.S. FDA Resources

Further study details as provided by GlaxoSmithKline:

Eligibility

Criteria

Inclusion Criteria: (Patient must meet these criteria in order to be eligible for this study.)

Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.

Exclusion Criteria: (Patient cannot meet these criteria in order to be eligible for this study.)

Patient has a current or past history of seizure disorder or brain injury.
Patient has a history or current diagnosis of anorexia nervousa or bulimia.
Patient has recurrent summer depression more frequently than winter depression.
Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
Patient has initiated psychotherapy within the last 3 months.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00046449

Sponsors and Collaborators

GlaxoSmithKline

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00046449 History of Changes
Obsolete Identifiers:	NCT00300144
Other Study ID Numbers:	398149
Study First Received:	September 30, 2002
Last Updated:	July 26, 2010
Health Authority:	United States: Food and Drug Administration

Additional relevant MeSH terms:

Seasonal Affective Disorder
Mood Disorders
Depressive Disorder
Mental Disorders

ClinicalTrials.gov processed this record on February 12, 2012